Generics-maker Teva Pharmaceutical has hired Gary Buehler, FDA's former head of generic drugs and outgoing deputy director, Office of Pharmaceutical Science. Buehler is set to retire from the FDA at the end of this week. He'll join Teva as VP for regulatory strategic operations. The drugmaker no doubt hopes to tap Buehler's insider insights for generics and biosimilars. Article